These stocks have an unusual volume in today's session
By Mill Chart
Last update: Sep 23, 2022
Let's have a look at the stocks with an unusual volume in today's session.
Today's unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| SLNG | -7.08% | So far 722.86K shares of STABILIS SOLUTIONS INC (NASDAQ:SLNG) have traded in today's session. The share price decreased by 7.08%. The average daily volume over 50 days is 472.72K, so this is 52.92% above the average volume. |
| VIRI | -5.63% | So far 1.29M shares of VIRIOS THERAPEUTICS INC (NASDAQ:VIRI) have traded in today's session. NASDAQ:VIRI is declining 5.63% today. The average daily volume over 50 days is 603.9K, so this is 114.0% above the average volume. Yesterday the company had a press release: Virios Therapeutics, Inc. Announces Closing of Public Offering. |
| CHNG | -0.09% | CHANGE HEALTHCARE INC's (NASDAQ:CHNG) traded a high volume of 5.56M shares. The share price decreased by 0.09%. The average daily volume over 50 days is 4.01M, so this is 38.59% above the average volume. |
| FDX | -3.64% | 4.32M shares of FEDEX CORP (NYSE:FDX) exchanged hands today. Leading to a price decrease of 3.64%. This is 57.07% above the average daily volume of the last 50 days. A press release (FedEx Corp. Reports First Quarter Results) was released yesterday. |
| SPRO | -5.05% | 34.99M shares of SPERO THERAPEUTICS INC (NASDAQ:SPRO) have been traded so far today. Shares are falling by 5.05%. This is 355.0% above the average daily volume of the last 50 days. |
| GSMGW | 0.5% | 397.94K shares of GLORY STAR NEW -CW25 (NASDAQ:GSMGW) exchanged hands today. NASDAQ:GSMGW is advancing 0.5% today. The average volume measured over 50 days is 185.67K, so this is 114.0% above the average volume. |
| LCA | 0.0% | So far 357.56K shares of LANDCADIA HOLDINGS IV INC-A (NASDAQ:LCA) have traded in today's session. This volume is 114.0% above the average 50 day volume. |
| HIII | 0.0% | HUDSON EXECUTIVE INVESTMEN-A's (NASDAQ:HIII) traded a high volume of 197.92K shares. This is 52.99% above the average daily volume of the last 50 days. |
| FCAX | -0.1% | 310.06K shares of FORTRESS CAPITAL ACQUISITI-A (NYSE:FCAX) have been traded so far today. The share price decreased by 0.1%. The average daily volume over 50 days is 120.84K, so this is 157.0% above the average volume. |
| CPAR | 0.0% | 228.05K shares of CATALYST PARTNERS ACQ-A (NASDAQ:CPAR) exchanged hands today. The average volume measured over 50 days is 147.27K, so this is 54.86% above the average volume. |
Our unusual volume stocks screener will show you the full list.
SPERO THERAPEUTICS INC
NASDAQ:SPRO (4/19/2024, 4:23:27 PM)
1.4
-0.07 (-4.76%)
SPRO News
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients
$95 million in development milestones payable over two years, as part of GSK license agreement...
6 months ago - Bragar Eagel & Squire, P.C.SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
